Vingmed and Injeq signed the distribution agreement for the Norwegian market

Vingmed AS is part of the Vingmed Group, one of the largest healthcare providers in the Nordic countries in areas such as anaesthesia and intensive care, health technology and clinical diagnostics. Vingmed consistently selects partners who invest in R&D and follow strict quality standards in their production.

In line with its values, Vingmed works closely and long-term with suppliers who are leaders in their respective industries; offer innovative, value-based solutions and services to the healthcare sector to ensure better and more cost-effective patient care. At Injeq, we are happy and satisfied with the agreement and believe that together we can create new openings.

Tiedote osakkeenomistajille / Notice to shareholders

TIEDOTE INJEQ OYJ:N OSAKKEENOMISTAJILLE NOTICE TO SHAREHOLDERS OF INJEQ PLC
Read more »

News release on April 12, 2024

The share issue of Injeq Plc. ended on April 5, 2024, and the investment round did not achieve the goals […]
Read more »

Information to shareholders, March 22nd, 2024

Injeq has started a share issue. The maximum of the financing round is set at €3,000,000. If the €2,000,000 goal […]
Read more »

Injeq webinars by Dr Sauli Palmu and Dr Harri Sievänen

Injeq webinar videos are now available! Welcome to participate in Dr. Sauli Palmu’s lecture “Lumbar punctures in pediatric hemato-oncology” (part […]
Read more »

New distributor agreement with “GENFAX SRL”

We are pleased to announce that GENFAX is appointed as INJEQ’s exclusive distributor in Romania. We are confident that our […]
Read more »

Injeq webinar today, Thursday Feb 22nd, 2024

Welcome to the webinar “Innovation in lumbar punctures” on February 22nd, 2024, at 7:00 pm (Madrid time Zone)   Lecturers […]
Read more »